Skip to content

Large-Bore Mechanic Thrombectomy for the Treatment of Symptomatic Portomesenteric Vein Thrombosis

Large-bore Mechanical Thrombectomy for the Treatment of Symptomatic Portomesenteric Vein Thrombosis

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06318754
Enrollment
0
Registered
2024-03-19
Start date
2025-03-31
Completion date
2027-03-31
Last updated
2025-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal Vein, Thrombectomy, Thrombosis

Brief summary

A single site study evaluating the safety, feasibility, and effectiveness of percutaneous large-bore mechanical thrombectomy using the Inari Triever Aspiration Catheter for the treatment of portomesenteric vein thrombosis (PMVT).

Detailed description

This is a single center, prospective, investigator-initiated observational study of adults undergoing mechanical thrombectomy as part of clinical care for portomesenteric vein thrombosis (PMVT).

Interventions

DEVICEInari Triever Aspiration Catheter

Inari Triever Aspiration Catheter for portomesenteric venous thrombosis

Sponsors

Inari Medical
CollaboratorINDUSTRY
University of Maryland, Baltimore
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years, * PMVT diagnosed on cross-sectional imaging such as contrast-enhanced CT or MRI abdomen * Symptomatic PMVT (persistent symptom, worsening abdominal pain after initiation of anticoagulation, development of peritonitis, complication of portal hypertension in cirrhosis (variceal bleeding or worsening ascites), and poor surgical candidates * Speaks and understands English language

Exclusion criteria

* Age \< 18 years * no PMVT diagnosed on cross-sectional imaging such as contrast-enhanced CT or MRI abdomen * Malignant PMVT * chronic PMVT including presence of cavernoma and network of prominent collateral vessels in porta hepatis on cross-sectional imaging. * asymptomatic PMVT * life expectancy \< 6 months * Does not speak or understand English language

Design outcomes

Primary

MeasureTime frameDescription
Technical SuccessTime of interventionUncomplicated transjugular access to the portal vein combined with uncomplicated implementation of the Inari Triever Aspiration Catheter for mechanical thrombectomy.
Clinical Success1 week, 1 month and 3 months post interventionPartial or complete resolution of patient's primary presenting symptoms, including ascites, gastrointestinal bleeding, and postprandial pain.
Primary Patency3 months post interventionUninterrupted patency without any repeat intervention.
Intermediate functional successTime of interventionRecanalization of the PMVT with re-established any level of hepatopetal flow in PMV system following Inari Flow Triever-assisted mechnical thrombectomy.

Secondary

MeasureTime frameDescription
Secondary Patency3 months post interventionUninterrupted patency in patient who underwent re-intervention due to recurrent thrombosis.
Duration of hospitalization3 months post interventionTime from admission to hospital to the time of discharge from hospital.
Duration of ICU days3 months post interventionTime from transfer to ICU to discharge/transfer from ICU
Blood loss during interventionAt time of interventionTotal amount of blood loss (mL) during the intervention
Transfusion3 months post interventionTotal amount of PRBC given post-intervention and number of patient's requiring transfusion post-intervention.
Major and minor complications1 week, 1 month, and 3 months post interventionSociety of Interventional Radiology major and minor complication will be used to categorize the complications.
30-day mortality30 days post interventionDeath occurring within 30 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026